In Brief: Merck, Hospira, Baxter particulates, EU GMP deficiencies, gelatin imports, aseptic deficiencies, UK labeling recalls
This article was originally published in The Gold Sheet
Executive Summary
Particulates are still prompting recalls at major U.S. manufacturers, EMA finds two plants in India deficient, FDA refuses certain gelatin excipient imports from India and Mexico, FDA finds aseptic deficiencies at two compounding pharmacies, and labeling mishaps spur two recalls in the UK.